1095PRUBIH2 - Use of NGS in haematological malignancies: From real world data to national recommendations, an innovative program to evaluate the impact of healthcare technology on patient care

ConclusionsFinal objective is to improve patient care and access to NGS based on better stratification and definition of analyses to perform at each stage of patient ’s care pathways: diagnostic, relapse and follow-up.Clinical trial identificationNCT03750994.Legal entity responsible for the studyAssistance Publique H ôpitaux de Paris.FundingDirection G énérale de l’Offre de Soins (DGOS) - French Ministry of Health.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research